Display options
Cite
Fox RJ, Rudick RA. Should patients with relapsing multiple sclerosis be given a higher dose and frequency of interferon-beta1a?. Nat Clin Pract Neurol. 2005;1(1):16-7doi: 10.1038/ncpneuro0041.
Fox, R. J., & Rudick, R. A. (2005). Should patients with relapsing multiple sclerosis be given a higher dose and frequency of interferon-beta1a?. Nature clinical practice. Neurology, 1(1), 16-7. https://doi.org/10.1038/ncpneuro0041
Fox, Robert J, and Rudick, Richard A. "Should patients with relapsing multiple sclerosis be given a higher dose and frequency of interferon-beta1a?." Nature clinical practice. Neurology vol. 1,1 (2005): 16-7. doi: https://doi.org/10.1038/ncpneuro0041
Fox RJ, Rudick RA. Should patients with relapsing multiple sclerosis be given a higher dose and frequency of interferon-beta1a?. Nat Clin Pract Neurol. 2005 Nov;1(1):16-7. doi: 10.1038/ncpneuro0041. PMID: 16932486.
Copy Download .nbib Format: NLM
Share it on

Nat Clin Pract Neurol. 2005 Nov;1(1):16-7. doi: 10.1038/ncpneuro0041.

Should patients with relapsing multiple sclerosis be given a higher dose and frequency of interferon-beta1a?.

Nature clinical practice. Neurology

Robert J Fox, Richard A Rudick

Affiliations

  1. Cleveland Clinic Foundation, Cleveland, OH 44195, USA. [email protected]

PMID: 16932486 DOI: 10.1038/ncpneuro0041

[No abstract available.]

Publication Types